Countries China

Novo Holdings Joins $290m Fundraising for Sangon Biotech

Based in China, and with close to 30 years in operation, Sangon Biotech is a leading provider of life science tools in China. The Company offers ...

 August 18, 2023 | News

Innovent's SINTBILO® Receives NMPA Approval for Treating Hypercholesterolemia

The prevalence of cardiovascular diseases is continuously increasing in China, among which atherosclerotic cardiovascular disease (ASCVD) is the leadi...

 August 17, 2023 | News

Infinitus & Jiangnan University Create Center for Herbal Medicine-Probiotic Combo

Lam Yu, CEO of Infinitus Global and Vice Chairman of Infinitus (China), expressed his enthusiasm in his speech, "Infinitus has been deeply involved in th...

 August 16, 2023 | News

FDA Grants Priority Review for Cefepime-Taniborbactam to Treat cUTI

Everest Medicines (HKEX 1952.HK)'s partner Venatorx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted the company's N...

 August 16, 2023 | News

Kelun-Biotech's Phase III Trial of SKB264 Meets Endpoint in Advanced TNBC

Kelun-Biotech recently held an Independent Data Monitoring Committee (IDMC) meeting to review the interim analysis data of the Phase III clinical trial of ...

 August 15, 2023 | News

Neurophth Raises Almost $95M for Gene Therapy Trials in Series C+ Funding

Additionally, several prominent investment firms participated, including CMG-SDIC Capital, Silicon Paradise Asset Management and Yangtze River Industry Fun...

 August 14, 2023 | News

Asieris Reports Successful Phase III Bridging Trial for Hexvix® in Bladder Cancer Diagnosis

The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...

 August 14, 2023 | News

WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services

Under the collaboration, Boostimmune will have access to WuXi Biologics' integrated discovery services and extensive expertise in antibody discovery, lead ...

 August 11, 2023 | News

First Patient Dosed in Phase III Prostate Cancer Imaging Study of TLX591-CDx in China

  The Phase III Illuccix China study (ClinicalTrials.gov ID: NCT05847348) is a prospective, open-label, single-arm, multicenter study in Chinese...

 August 11, 2023 | News

Positive Phase 3 Results for Fasedienol Nasal Spray in Social Anxiety Disorder by AffaMed's Partner Vistagen

First positive U.S. Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years Statistically significant rapid-onset reducti...

 August 11, 2023 | News

Mindray & Operation Smile Launch 10-Year Partnership to Enhance Healthcare for Vulnerable Communities

As a globally trusted innovator in medical devices and solutions, Mindray brings cutting-edge technology and medical expertise to the collaboration. Throug...

 August 09, 2023 | News

GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs

 GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has ramped up production of complex and modi...

 August 09, 2023 | News

DualityBio, BioNTech Expand Partnership for Solid Tumor Antibody-Drug Conjugate

The agreement further builds upon the strategic collaboration the companies announced in April 2023. Under the terms of the agreements, DualityBio will re...

 August 08, 2023 | News

Gracell Biotechnologies Secures Up to $150M in Private Placement with Premier Healthcare Investors

$100 million financing upfront with up to an additional $50 million tied to exercise of warrants Aggregate financing expected to extend c...

 August 08, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close